Allele Dmel\lwr4-3
| General Information | |||
|---|---|---|---|
| Symbol | Dmel\lwr4-3 | Species | D. melanogaster |
| Name | FlyBase ID | FBal0122957 | |
| Feature type | allele | Associated gene | Dmel\lwr |
| Allele class | hypomorphic allele - genetic evidence | ||
| Mutagen | Delta2-3 | ||
Recent Updates
|
|||
| Description |
What does this section display?
This section contains items that were added to this record for each release.
It currently only tracks new links between this FlyBase report and other
FlyBase data classes (e.g. genes, references, stocks) or controlled
vocabulary terms (e.g. GO, anatomy terms).
What does this section not display?
This section does not currently display links that were removed or gene model changes.
|
||
| Update Feed |
Click the icon below to subscribe to this FlyBase record and receive updates automatically through your
feed reader.
|
||
| FB2013_03 | |||
| FB2013_02 | |||
| All updates | Click here to see a list of all updates to this record from FB2010_08 and on. | ||
Nature of the Allele
| |||
| Allele class | |||
| Mutagen | |||
| Mutations Mapped to the Genome | |||
Type Location Additional Notes References | |||
| Associated Sequence Data | |||
| DDBJ
/
EMBL / GenBank | DNA sequence Protein sequence Name | ||
| UniProtKB/Swiss-Prot | |||
| UniProtKB/TrEMBL | |||
| Progenitor genotype | |||
| Nature of the lesion | Statement Reference | ||
| Caused by insertion | |||
| Cytology | |||
Phenotypic Data
| |||
Phenotypic Class
| |||
tumorigenic (with lwr5) | |||
Phenotype Manifest In
| |||
crystal cell (with lwr5) crystal cell (with lwr14) hemocyte & nucleus | supernumerary (with lwr14) | |||
Detailed Description
| |||
Statement Reference Over 90% of lwr4-3/lwr5 larvae have melanotic tumours, which are surrounded by lamellocytes, while only ~20% of lwr4-3/lwr14 larvae show this phenotype. Four days after egg lay, percentages of circulating hemocytes and lamellocytes are significantly higher in lwr4-3/lwr5 mutants than in controls, while lwr4-3/lwr14 mutants show high lamellocyte percentages, but have circulating hemocyte levels that are within control range. Levels of circulating hemocytes continue to increase six days after egg lay in lwr4-3/lwr5 mutants, but do not further increase after eight days. More than 6% of lwr4-3/lwr14 hemocytes, in both lymph glands and in circulation, are multinucleate and some hemocytes are abnormally large. lwr4-3/lwr5 mutants also exhibit large hemocytes but show a lower penetrance of multinucleate hemocytes. There is a 5- to 10-fold reduction in crystal cells in both lwr4-3/lwr5 and lwr4-3/lwr14 mutants. lwr4-3/lwr5 mutants show a developmental delay and only 25% undergo pupariation on day 8. lwr4-3 mutants develop melanotic tumours during the third larval stage, which become particularly large in the posterior half of the body. In some cases, hemocytes can invade self-tissues such as fat body cells. The number of hemocytes in the hemolymph of lwr4-3/lwr5 mutant larvae is significantly higher than in wild type and the number of lamellocytes is increased within the hemocyte pool. Most aggregated hemocytes consist of lamellocytes that are partially to fully melanized. Mitotic analyses of hemocytes show that lamellocytes do not divide in circulation so the excess number must be due to proliferation in the lymph gland. However, plasmatocytes and prohemocytes do divide in circulation in lwr4-3/lwr5 mutants, while no such division occurs in wild type. | |||
External Data
| |||
| Linkouts | |||
Interactions
| |||
|
|||
Phenotypic Class
| |||
Suppressed by | |||
Statement Reference lwr5/lwr4-3 has melanotic mass phenotype | larval stage phenotype, suppressible | partially by cactE8/cactE10 lwr5/lwr4-3 has melanotic mass phenotype | larval stage phenotype, suppressible | partially by Df(2L)J4/dl1 lwr5/lwr4-3 has melanotic mass phenotype | larval stage phenotype, suppressible | partially by Df(2L)TW119/Dif1 lwr5/lwr4-3 has melanotic mass phenotype | larval stage phenotype, suppressible by Df(2L)TW119/Df(2L)J4 | |||
Other | |||
Statement Reference | |||
Phenotype Manifest In
| |||
Suppressed by | |||
Statement Reference lwr5/lwr4-3 has embryonic/larval hemocyte | supernumerary phenotype, suppressible | partially by Df(2L)J4/Dif2 lwr5/lwr4-3 has embryonic/larval hemocyte | supernumerary phenotype, suppressible | partially by Df(2L)J4/dl1 lwr5/lwr4-3 has embryonic/larval hemocyte | supernumerary phenotype, suppressible by Df(2L)TW119/Df(2L)J4 | |||
NOT suppressed by | |||
Statement Reference | |||
Additional Comments
| |||
Genetic Interactions
| |||
Statement Reference The penetrance of melanotic tumours is reduced from over 90% in lwr4-3/lwr5 mutants to less than 2% in lwr4-3 Df(2L)TW119/lwr5 Df(2L)J4 triple mutants. The amount of circulating hemocytes and lamellocytes are reduced by day 8 in lwr4-3 Df(2L)TW119/lwr5 Df(2L)J4 triple mutants compared to lwr4-3/lwr5 single mutants. The melanotic tumour penetrance and circulating hemocyte levels are reduced in lwr4-3 Df(2L)J4/lwr5 dl1 and lwr4-3 Df(2L)TW119/lwr5 Dif1 double mutants, but to a lower extent than in lwr4-3 Df(2L)TW119/lwr5 Df(2L)J4 triple mutants. However, the amount of lamellocytes is not reduced in the double mutants. The melanotic tumour penetrance is reduced in lwr4-3 cactE8/lwr5 cactE10 double mutants compared to lwr4-3/lwr5 single mutants and by day 8, the amount of circulating hemocytes is reduced in the double mutants. In contrast, the amount of lamellocytes remains as high as in the single mutants. In lwr4-3/lwr5; dl1/Df(2L)J4, total numbers of hemocytes are reduced compared to lwr4-3/lwr5 single mutants. Plasmatocyte levels are reduced by 50% compared to single mutants, while lamellocyte levels are not significantly reduced. In lwr4-3/lwr5; Dif2/Df(2L)J4 double mutants the number of lamellocytes are the same as in wild-type larvae, while the number of plasmatocytes is reduced compared to lwr4-3/lwr5 single mutants, but remain higher than in wild type. In lwr4-3/lwr5; Df(2L)TW119/Df(2L)J4 double mutants, the total number of hemocytes, including lamellocytes, is the same as wild type. | |||
Xenogenetic Interactions
| |||
Statement Reference | |||
Complementation & Rescue Data
| |||
| Complements | |||
| Fails to complement | |||
| Rescued by | |||
| Partially rescued by | |||
| Comments | Expression of lwr[Scer\UAS.cAa] in a subset of the lymph gland cells under the control of Scer\GAL4[76B] significantly reduced the infiltration index in lwr[4-3]/lwr[5] mutants, indicating an anti-inflammatory role for lwr. Expression of lwrScer\UAS.cAa under the control of Scer\GAL4Cg.PA partially rescues the developmental delay of lwr4-3/lwr5 mutants, increasing the amount of animals undergoing pupariation from 25 to 61% at day 8. However, there is no clear rescue of the melanotic tumour phenotype. lwrScer\UAS.cAa rescues lwr4-3/lwr5 females to adulthood when expressed using Scer\GAL4e22c or Scer\GAL4nos.PG, however the rescued flies are sterile. The ovaries develop to stage 8 or 9 (Scer\GAL4nos.PG) or stage 2 (Scer\GAL4e22c). | ||
Stocks
( 1 ) | |||
| Bloomington | |||
Notes on Origin
| |||
| Discoverer | |||
External Crossreferences & Linkouts
| |||
| Other Crossreferences | |||
| Linkouts | |||
Synonyms & Secondary IDs
( 2 ) | |||
| Reported As | |||
| Symbol Synonym | Ubc94-3 | ||
| Name Synonym | |||
| Secondary FlyBase IDs | |||
References
( 9 ) | |||
| Research paper |
| ||
Recent Updates
External Crossreferences & Linkouts